NO20030115D0 - Kontrastmiddel - Google Patents
KontrastmiddelInfo
- Publication number
- NO20030115D0 NO20030115D0 NO20030115A NO20030115A NO20030115D0 NO 20030115 D0 NO20030115 D0 NO 20030115D0 NO 20030115 A NO20030115 A NO 20030115A NO 20030115 A NO20030115 A NO 20030115A NO 20030115 D0 NO20030115 D0 NO 20030115D0
- Authority
- NO
- Norway
- Prior art keywords
- imaging agents
- formula
- moiety
- angiotensin
- affinity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0819—Tripeptides with the first amino acid being acidic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Light Receiving Elements (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20030115A NO20030115D0 (no) | 2003-01-09 | 2003-01-09 | Kontrastmiddel |
DE602004020049T DE602004020049D1 (de) | 2003-01-09 | 2004-01-09 | Kontrastmittel |
US10/541,949 US7919071B2 (en) | 2003-01-09 | 2004-01-09 | Contrast agent |
AT04701136T ATE425770T1 (de) | 2003-01-09 | 2004-01-09 | Kontrastmittel |
JP2006500737A JP2006517539A (ja) | 2003-01-09 | 2004-01-09 | 造影剤 |
CNA2004800019549A CN1723043A (zh) | 2003-01-09 | 2004-01-09 | 造影剂 |
PCT/NO2004/000002 WO2004062568A2 (en) | 2003-01-09 | 2004-01-09 | Conjugate of losartan, valsartan, candesartan or eprosartan and a chelant as contrast agent |
EP04701136A EP1581262B1 (en) | 2003-01-09 | 2004-01-09 | Contrast agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20030115A NO20030115D0 (no) | 2003-01-09 | 2003-01-09 | Kontrastmiddel |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20030115D0 true NO20030115D0 (no) | 2003-01-09 |
Family
ID=19914362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20030115A NO20030115D0 (no) | 2003-01-09 | 2003-01-09 | Kontrastmiddel |
Country Status (8)
Country | Link |
---|---|
US (1) | US7919071B2 (no) |
EP (1) | EP1581262B1 (no) |
JP (1) | JP2006517539A (no) |
CN (1) | CN1723043A (no) |
AT (1) | ATE425770T1 (no) |
DE (1) | DE602004020049D1 (no) |
NO (1) | NO20030115D0 (no) |
WO (1) | WO2004062568A2 (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO20034350D0 (no) * | 2003-09-29 | 2003-09-29 | Amersham Health As | Optisk avbilding av kolorektal kreft |
US7431914B2 (en) | 2003-11-24 | 2008-10-07 | Ge Healthcare As | Contrast agent |
DE602005017475D1 (de) | 2004-03-04 | 2009-12-17 | Ge Healthcare As | Konjugate von angiotensin-peptid analoga und chelatbildner für diagnose und therapie |
FR2902428B1 (fr) * | 2006-06-15 | 2008-08-15 | Servier Lab | Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
WO2008058551A1 (en) * | 2006-11-13 | 2008-05-22 | Telefonaktiebolaget L M Ericsson (Publ) | Wireless telecommunications systems |
DE602007007362D1 (de) * | 2006-12-11 | 2010-08-05 | Ge Healthcare As | Radioaktiv markierte verbindungen auf peptidbasis und ihre verwendung |
TW201215388A (en) * | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
GB201103696D0 (en) | 2011-03-04 | 2011-04-20 | Ge Healthcare Ltd | Technetium labelled peptides |
GB201314936D0 (en) | 2013-08-21 | 2013-10-02 | Ge Healthcare Ltd | Radiolabelling method |
GB201322456D0 (en) | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Radiotracer compositions and methods |
WO2019134765A1 (en) | 2018-01-08 | 2019-07-11 | Julius-Maximilians-Universitaet Wuerzburg | Sartan analogue |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0365378A (ja) * | 1989-08-04 | 1991-03-20 | Tokyo Tatsuno Co Ltd | 複写伝票 |
US5808091A (en) * | 1991-10-29 | 1998-09-15 | Bracco International B.V. | Rhenium and technetium complexes containing a hypoxia localizing moiety |
JPH09165378A (ja) | 1995-12-15 | 1997-06-24 | Seitai Kinou Kenkyusho:Kk | N1−[18f]フルオロベンジル複素環化合物およびそれらの製造法 |
WO1998018496A2 (en) * | 1996-10-28 | 1998-05-07 | Nycomed Imaging As | Contrast agents |
PT1272507E (pt) | 2000-04-12 | 2005-11-30 | Amersham Health As | Derivados de peptidos para ligacao a integrina |
AU6972901A (en) | 2000-05-31 | 2001-12-11 | Mayo Foundation | Cobalamin compounds useful as cardiovascular agents and as imaging agents |
GB0031592D0 (en) * | 2000-12-28 | 2001-02-07 | Nycomed Amersham Plc | Stabilised radiopharmaceutical compositions |
GB0105224D0 (en) * | 2001-03-02 | 2001-04-18 | Nycomed Amersham Plc | Improved peptide-chelate conjugates |
GB0116815D0 (en) | 2001-07-10 | 2001-08-29 | Nycomed Amersham Plc | Improved chelator conjugates |
CA2452923C (en) * | 2001-07-10 | 2012-02-07 | Amersham Health As | Peptide-based compounds for targeting integrin receptors |
-
2003
- 2003-01-09 NO NO20030115A patent/NO20030115D0/no unknown
-
2004
- 2004-01-09 CN CNA2004800019549A patent/CN1723043A/zh active Pending
- 2004-01-09 US US10/541,949 patent/US7919071B2/en not_active Expired - Fee Related
- 2004-01-09 JP JP2006500737A patent/JP2006517539A/ja active Pending
- 2004-01-09 WO PCT/NO2004/000002 patent/WO2004062568A2/en active Application Filing
- 2004-01-09 DE DE602004020049T patent/DE602004020049D1/de not_active Expired - Lifetime
- 2004-01-09 EP EP04701136A patent/EP1581262B1/en not_active Expired - Lifetime
- 2004-01-09 AT AT04701136T patent/ATE425770T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20070020176A1 (en) | 2007-01-25 |
US7919071B2 (en) | 2011-04-05 |
WO2004062568A3 (en) | 2004-09-30 |
EP1581262A2 (en) | 2005-10-05 |
WO2004062568A2 (en) | 2004-07-29 |
CN1723043A (zh) | 2006-01-18 |
JP2006517539A (ja) | 2006-07-27 |
DE602004020049D1 (de) | 2009-04-30 |
EP1581262B1 (en) | 2009-03-18 |
ATE425770T1 (de) | 2009-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04000173A (es) | Compuestos basados en peptidos. | |
NO20073039L (no) | Kontrastmidler | |
ATE425770T1 (de) | Kontrastmittel | |
DK1272507T3 (da) | Integrinbindende peptidderivater | |
SG149895A1 (en) | Contrast agents for myocardial perfusion imaging | |
WO2003105757A3 (en) | METHODS AND COMPOSITIONS FOR MEDIA-DEPENDENT BINDING OF A TARGET AGENT TO A TARGET | |
ATE439868T1 (de) | Targetingmittel für molekulare bilderzeugung | |
HK1097278A1 (en) | Imaging agents | |
ATE314097T1 (de) | Kontrastmittel | |
WO1998018497A3 (en) | Contrast agents | |
HUP0301835A2 (hu) | Kationos diagnosztikai, képalkotó és terápiás ágensek, aktivált vaszkuláris helyekkel asszociálódva | |
DE602005024279D1 (de) | 5-substituierte-2-phenylaminobenzamide als mek-inhibitoren | |
GB0326546D0 (en) | Inhibitor imaging agents | |
DE69841322D1 (de) | Hepatitis c rezeptorprotein cd81 | |
ATE310736T1 (de) | Verbindungen zur bilddarstellung der alzheimer- krankenheit | |
WO2007064661A3 (en) | Bifunctional metal chelating conjugates | |
NO20033115D0 (no) | Peptid-baserte forbindelser | |
ATE480552T1 (de) | Stq-peptide | |
WO2005049095A3 (en) | Contrast agent imaging angiotensin ii receptors | |
TW200616950A (en) | Synthesis of indole analogs of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole (yc-1) as anti-platelet agents | |
ITMI20031790A1 (it) | Antagonistici abiotici dell'eparina. | |
DE60316775D1 (de) | Kombinationspräparat aus epothilone derivate und imidazotetrazinone | |
WO2007101252A3 (en) | Targeted delivery of pharmaceutical compounds | |
HN2002000112A (es) | Sal citrato de 5, 8,14 - triazatetraciclo [10.3.1.02.11.04.9] - hexadeca - 2 (11),3,5,7,9 - pentaeno y composiciones farmaceuticas de la misma. | |
TW200628170A (en) | Contrast agents for myocardial perfusion imaging |